Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

The INCATE team at the AMR conference in Basel 2024
© eventfotografen.com / bamconn GmbH

INCATE receives Lighthouse Award 2024 from Swiss National Science Foundation

INCATE, the INCubator for Antimicrobial Therapies in Europe co-founded by the German Center for Infection Research, has been honoured with the 2024 Lighthouse Award for outstanding Transfer of

Prof. Dr Marc Huebner and Prof. Dr Achim Hoerauf
© Universitätsklinikum Bonn

Award for drug research on river blindness and elephantiasis

DZIF professors Marc Hübner and Achim Hörauf are part of the international team that has now been awarded the Horizon Prize 2024 by the Royal Society of Chemistry.
Cell cultures in an incubator
© HMGU

New perspectives for patients: National Strategy for Gene- and Cell-based Therapies

Around 150 experts from various stakeholder groups—including a number of scientists from the network of the German Center for Infection Research (DZIF)—have developed a roadmap for improving

DZIF Academy logo and icon in paper form with award on red-magenta background
© hunthomas/Adobe Stock

Apply now: DZIF Prize for Translational Infection Research 2024

The German Center for Infection Research (DZIF) is again offering the DZIF Prize for Translational Infection Research. Scientists can apply to the DZIF Academy until 6 October 2024. A prize of 5,000

EM image of brown-coloured rod-shaped Klebsiella bacteria
© HZI/Müsken

How bacterial members of the microbiome specifically fight Salmonella infections

The microbiome, i.e. the microorganisms that colonise our gut and help with digestion, weighs around one and a half kilograms. It consists primarily of bacteria and also has a protective effect

Parliamentary Group against antimicrobial Resistance
© DNAMR/Konrad

Parliamentary Group against Antimicrobial Resistance founded

Members of Parliament (MPs) from the CDU, FDP, SPD and Die Linke parties have joined forces in a parliamentary group to focus more on combating antimicrobial resistance in the future.

Antibacterial

Staphylococcus aureus
© NIAID

Innovative Phage Lysin HY-133 enters phase I clinical study

HYpharm's innovative preventive agent HY-133 has reached the first clinical trial phase. HY-133 is specifically effective against the bacterial pathogen Staphylococcus aureus including multi-resistant

Professor Marcus Altfeld is new director of the Leibniz Institute of Virology in Hamburg

On 1 June 2024, Professor Marcus Altfeld, Coordinator of the research area HIV at the German Center for Infection Research (DZIF), became Scientific Director of the Leibniz Institute of Virology (LIV)

Prof. Dr Christoph M. Ernst
© Michael Wodak

Funding from the Boehringer Ingelheim Foundation for Prof Christoph Ernst

Prof. Dr Christoph Ernst from the Institute of Medical Microbiology, Immunology and Hygiene at the University Hospital of Cologne and the Faculty of Medicine has been selected for the Boehringer

Portraits of DSMZ scientists Sabine Grownow and Birte Abt
© DSMZ

DZIF makes resistant bacterial strains from the WHO pathogen list available for international antibiotics research

According to estimates, 4.95 million deaths worldwide in 2019 were directly or indirectly attributable to infections with resistant bacteria. The rising number of resistant bacterial pathogens, also